All instruments
Lincoln Pharmaceuticals Limited
- Stock
- LINCOLN
- NSE
- ₹545.60−1.69%
- Delayed close, 16 Oct
Details
- INE405C01035
- Healthcare
- Pharmaceuticals
- Face value ₹10
- Market cap ₹1,093 Cr
Paid for 20 years without a break
Dividend per share by FY
Split-adjusted · FY27 to date · last 7 of 20 years · FY of the ex-date
| Financial year | Total dividend |
|---|---|
| FY02 | ₹0.80 |
| FY08 | ₹0.24 |
| FY09 | ₹0.24 |
| FY10 | ₹1.20 |
| FY11 | ₹1.20 |
| FY12 | ₹0.60 |
| FY13 | ₹0.60 |
| FY14 | ₹0.60 |
| FY15 | ₹0.60 |
| FY16 | ₹1.00 |
| FY17 | ₹1.00 |
| FY18 | ₹1.20 |
| FY19 | ₹1.50 |
| FY20 | ₹3.00 |
| FY22 | ₹1.50 |
| FY23 | ₹1.50 |
| FY24 | ₹1.50 |
| FY25 | ₹1.80 |
| FY26 | ₹1.80 |
| FY27 | ₹1.80 |
TTM payout
₹1.80
1 payout in 12 months
Yield
0.33%
Dividend yield · trailing 12 months
52-wk closing range ₹444.20 – ₹758.15
Yield and payout totals recalculated 18 Oct 2026.
Recent payouts
· 21 on record since FY02| Ex-date | Type | Record date | Amount |
|---|---|---|---|
| 11 Sep 2026 | Final | same day | ₹1.80 |
| 12 Sep 2025 | Final | same day | ₹1.80 |
| 13 Sep 2024 | Final | — | ₹1.80 |
| 15 Sep 2023 | Final | — | ₹1.50 |
| 15 Sep 2022 | Final | — | ₹1.50 |
Income calculator
₹329
Expected income per year, before tax, at the current 0.33% yield
≈ 183 shares at ₹545.60, using ₹99,845 of the ₹1,00,000. Based on the last twelve months’ payouts — not a forecast, and dividends are taxed at your own slab rate.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.